Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.43 |
| ▸ | ESR1 | P03372 | 2/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.38 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27722609 | 0.79 | CA2 (0.41) | KMT2AALDH1A1MAPK1CYP1A2CYP2C19 | |
| SCHEMBL13068858 | 0.79 | KCNN4 (0.43) | KCNN4MAPTKMT2AALDH1A1CYP3A4 | |
| SCHEMBL27847412 | 0.79 | MEN1 (0.48) | KMT2AMAPK1CYP1A2CYP2C19HIF1A | |
| SCHEMBL6284155 | 0.77 | KIF11 (0.43) | MAPTKMT2AALDH1A1CYP3A4MAPK1 | |
| SCHEMBL6846285 | 0.77 | CASR (0.45) | ALDH1A1CYP3A4CYP1A2CYP2D6SLC6A2 | |
| SCHEMBL2898192 | 0.76 | KCNN4 (0.46) | KCNN4MAPTKMT2ATAAR1ESR1 | |
| SCHEMBL28442672 | 0.76 | CYP19A1 (0.51) | CYP3A4CYP1A2 | |
| SCHEMBL2121346 | 0.75 | ESR1 (0.44) | KCNN4MAPTKMT2ATAAR1ESR1 | |
| SCHEMBL6379504 | 0.75 | KCNN4 (0.50) | KCNN4MAPTKMT2ATAAR1ALDH1A1 | |
| Acetaldehyde SCHEMBL8461177 | 0.75 | KCNN4 (0.50) | KCNN4MAPTKMT2ATAAR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8962889-B2 | Process for producing optically active β-amino aldehyde compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-02-24 | — | — | US | disclosed |
| EP-2631228-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE B-AMINO ALDEHYDE COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2013-08-28 | — | — | EP | disclosed |
| US-20130211139-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE BETA-AMINO ALDEHYDE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-08-15 | — | — | US | disclosed |
| CN-103189352-A | Process for producing optically active [beta]-amino aldehyde compound | SUMITOMO CHEMICAL CO | 2013-07-03 | — | — | CN | disclosed |
| US-20110268697-A1 | Hepatitis C Virus Inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2011-11-03 | — | — | US | disclosed |
| EP-2248811-A1 | 2-OXOCHROMENE DERIVATIVE | Kowa Company, Ltd. (JP) | 2010-11-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130211139-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE BETA-AMINO ALDEHYDE COMPOUND | ALDH7A1, ALDH1A2, ALDH18A1 | KCNN4 3768/4885MAPT 1860/4885KMT2A 1531/4885 |
| US-20110268697-A1 | Hepatitis C Virus Inhibitors | HAVCR2, PYGL, HCCS | KCNN4 4880/4885MAPT 4065/4885KMT2A 4516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.